Company Biotricity, Inc. Other OTC
Equities
BTCY
US09074H1041
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Technology Fees
91.3
%
| 6 | 77.2 % | 9 | 91.3 % | +49.08% |
Device
8.7
%
| 1 | 13.0 % | 1 | 8.7 % | -15.95% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 8 | 100.0 % | 10 | 100.0 % | +26.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Waqaas Al-Siddiq
CEO | Chief Executive Officer | 39 | 28/08/12 |
John Ayanoglou
DFI | Director of Finance/CFO | 57 | 26/10/17 |
Spencer LaDow
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/16 |
Amir Ali
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald McClurg
BRD | Director/Board Member | 65 | 03/05/22 |
Chet White
BRD | Director/Board Member | 59 | 10/08/22 |
David Rosa
BRD | Director/Board Member | 59 | 02/05/16 |
Waqaas Al-Siddiq
CEO | Chief Executive Officer | 39 | 28/08/12 |
Chet White
BRD | Director/Board Member | - | 31/08/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 220 | 0 | 0 | 86.72 % |
Stock B | 1 | 160,672 | 0 | 0 | |
Stock C | 0 | 6,304 | 0 | 0 | |
Stock D | 1 | 11,435,965 | 10,057,054 ( 87.94 %) | 0 | |
Stock E | 0 | 1 | 0 | 0 |
Company contact information
Biotricity, Inc.
203 Redwood Shores Parkway Suite 600
94065, Redwood City
+(800) 590-4155
http://www.biotricity.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-17.59% | 2.74B | |
+2.53% | 187M | |
-16.53% | 80.66M |